Influence of acarbose and glibenclamide on insulin sensitivity in type 2 diabetes:: Results of a clamp-study

被引：0
|
作者：
Fischer, S [1 ]
Hanefeld, M [1 ]
Rietzsch, H [1 ]
Patzak, A [1 ]
Schwanebeck, U [1 ]
Wildbrett, J [1 ]
Fücker, K [1 ]
机构：
[1] Tech Univ Dresden, Fac Med, Dresden, Germany
来源：
DIABETOLOGIA | 1998年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
904
引用
收藏
页码：A234 / A234
页数：1
相关论文
共 50 条
  • [1] Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients
    Fischer, S
    Patzak, A
    Rietzsch, H
    Schwanebeck, U
    Köhler, C
    Wildbrett, J
    Fuecker, K
    Temelkova-Kurktschiev, T
    Hanefeld, M
    DIABETES OBESITY & METABOLISM, 2003, 5 (01): : 38 - 44
  • [2] Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes
    Hanefeld, M
    Haffner, SM
    Menschikowski, M
    Koehler, C
    Temelkova-Kurktschiev, T
    Wildbrett, J
    Fischer, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 55 (03) : 221 - 227
  • [3] Effect of acarbose versus sulfonylurea therapy on insulin sensitivity: An insulin clamp study
    Kinoshita, T
    Maeda, H
    Urata, S
    Hirao, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (02): : 97 - 104
  • [4] Acarbose combined with glibenclamide improves the glycemic control in type 2 diabetes patients
    Thervet, F
    Le Berre, MA
    Grange, V
    DIABETES, 2000, 49 : A366 - A366
  • [5] Hypoglycaemia leads to Platelet- and Coagulation Activation in Patients with Type 2 Diabetes under Metformin-Monotherapy - Results of hyperinsulinaemic hypoglycaemic Clamp-Study
    Aberer, Felix
    Pferschy, Peter
    Tripolt, Norbert
    Sourij, Caren
    Obermayer, Anna Maria
    Prueller, Florian
    Novak, Eva
    Reitbauer, Philipp
    Kojzar, Harald
    Prietl, Barbara
    Kofler, Selina
    Brunner, Martina
    Svehlikova, Eva
    Stojakovic, Tatjana
    Scharnagl, Hubert
    Oulhaj, Abderrahim
    Aziz, Faisal
    Riedl, Regina
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S461 - S462
  • [6] Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study
    Li, Feng-fei
    Xu, Xiao-hua
    Fu, Li-yuan
    Su, Xiao-fei
    Wu, Jin-dan
    Lu, Chun-feng
    Ye, Lei
    Ma, Jian-hua
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015
  • [7] Influence of acarbose on postprandial insulin requirements in patients with type 1 diabetes
    Juntti-berggren, L
    Pigon, J
    Holst, JJ
    Efendic, S
    DIABETOLOGIA, 1998, 41 : A230 - A230
  • [8] Effects on blood pressure of the α-glucosidase inhibitor acarbose compared with the insulin enhancer glibenclamide in patients with hypertension and type 2 diabetes mellitus
    Rosenthal, JH
    Mauersberger, H
    CLINICAL DRUG INVESTIGATION, 2002, 22 (10) : 695 - 701
  • [9] Effects on Blood Pressure of the α-Glucosidase Inhibitor Acarbose Compared with the Insulin Enhancer Glibenclamide in Patients with Hypertension and Type 2 Diabetes Mellitus
    Julian H. Rosenthal
    Herbert Mauersberger
    Clinical Drug Investigation, 2002, 22 : 695 - 701
  • [10] Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients
    Mayorov, AY
    Naumenkova, IV
    Antsiferov, MB
    Dedov, II
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (01) : S54 - S59
12345